InfuCare Rx, one of the nation's largest independent providers of specialty infusion services, announced it has completed a recapitalization of the business through a strategic founder-led equity buyback. Guggenheim Investments served as the strategic capital partner on behalf of certain of its clients for this milestone transaction. This transaction underscores InfuCare Rx management’s long-term commitment to the firm’s vision and values.